Offer - Urjas Oil for just ₹ 1 X
Erlonat 150 Tablet is a prescription drug, available for use as Tablet. Pancreatic Cancer, Non-Small Cell Lung Cancer are some of its major therapeutic uses.
The right dosage of Erlonat 150 Tablet depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Erlonat 150 Tablet can also lead to other problems, which have been listed below. Such side effects of Erlonat 150 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Erlonat 150 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Erlonat 150 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Erlonat 150 Tablet is contraindicated in people with pre-existing medical conditions like Liver Disease, Kidney Disease, Lung Disease as it can result in adverse effects. Other contraindications of Erlonat 150 Tablet have been discussed in the sections ahead.
Drug reaction of Erlonat 150 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Erlonat 150 Tablet is considered not safe while driving, and is not addictive.
Erlonat 150 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Erlonat 150 Tablet safe for pregnant women?
Erlonat may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlonat, and talk to their doctor, if they notice any discomfort.
Is the use of Erlonat 150 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erlonat. If you see any side effects, stop taking Erlonat immediately and talk to your doctor. Take Erlonat again, only after your doctor's advice.
What is the effect of Erlonat 150 Tablet on the Kidneys?
Erlonat does not damage the kidneys.
What is the effect of Erlonat 150 Tablet on the Liver?
Erlonat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlonat 150 Tablet on the Heart?
You can take Erlonat without any fear of damage to the heart.
Erlonat 150 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Erlonat 150 Tablet unless your doctor advises you to do so -
Is this Erlonat 150 Tablet habit forming or addictive?
Erlonat 150 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Erlonat 150 Tablet. So it is best to avoid driving.
Is it safe?
Erlonat 150 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Erlonat 150 Tablet for mental disorders.
Interaction between Food and Erlonat 150 Tablet
Some foods when eaten with Erlonat 150 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlonat 150 Tablet
It is difficult to say anything about the effect of Erlonat 150 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516